Early research (Phase 1)WithdrawnNCT02487459
What this trial is testing
Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
Who this might be right for
Hematologic Malignancies
Bellicum Pharmaceuticals
Showing 20 of 0 results